SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-060212
Filing Date
2023-11-07
Accepted
2023-11-07 16:03:20
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K asnd-20230930.htm   iXBRL 6-K 2010828
2 GRAPHIC img147639914_0.jpg GRAPHIC 23893
3 GRAPHIC img147639914_1.jpg GRAPHIC 90130
4 GRAPHIC img147639914_2.jpg GRAPHIC 52874
  Complete submission text file 0000950170-23-060212.txt   7137832

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asnd-20230930_lab.xml EX-101.LAB 372828
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asnd-20230930_pre.xml EX-101.PRE 272196
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asnd-20230930_cal.xml EX-101.CAL 45575
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asnd-20230930_def.xml EX-101.DEF 179426
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asnd-20230930.xsd EX-101.SCH 52415
47 EXTRACTED XBRL INSTANCE DOCUMENT asnd-20230930_htm.xml XML 1294740
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 231383590
SIC: 2834 Pharmaceutical Preparations